Skip to main content

Table 1 The correlation between miR-29b-2-5p expression levels and the clinical characteristics

From: MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma

Characteristics

Cases

miR-29b-2-5p expression in PDAC

 

Low(%)

High(%)

P value

Age (years)

   

0.689

 < 60

48

25(52.1)

23(47.9)

 

 ≥ 60

52

27(51.9)

25(48.1)

Gender

   

0.028*

 Male

61

33(54.1)

28(45.9)

 

 Female

39

19(48.7)

20(51.3)

Location of tumor

   

0.072

 Head

59

27(45.8))

32(54.2)

 

 Body or tail

41

25(61)

16(39)

Type of operation

   

0.088

 Pancreaticoduodenectomy

77

43(55.8)

34(44.2)

 

 Distal pancreatectomy

23

9(39.1)

14(60.9)

 Total pancreatectomy

0

0

0

Maximum tumor diameter (cm)

   

0.11

 < 4

42

28(66.7)

14(33.3)

 

 ≥ 4

58

24(41.4)

34(58.6)

Differentiation

   

< 0.001*

 Well

25

13(52)

12(48)

 

 Moderately

59

28(47.5)

31(52.5)

 Poor

16

11(68.8)

5(31.2)

Surgical margins

   

< 0.001*

 Negative

97

51(52.6)

46(47.4)

 

 Positive

3

1(33.3)

2(66.7)

pT category

   

0.002*

 pT1

11

7(63.6)

4(36.4)

 

 pT2

38

20(52.6)

18(47.4)

 pT3

24

12(50)

12(50)

 pT4

27

13(48.2)

14(51.8)

pN category

   

< 0.001*

 pN0

73

37(50.7)

36(49.3)

 

 pN1

27

15(55.6)

12(44.4)

Vessel invasion

   

0.841

 No

51

32(62.8)

19(37.2)

 

 Yes

49

20(40.8)

29(59.2)

Vascular tumor thrombus

   

< 0.001*

 No

97

49(50.5)

48(49.5)

 

 Yes

3

3(100)

0

Adjacent organs invasion

   

< 0.001*

 No

83

43(51.8)

40(48.2)

 

 Yes

17

9(52.9)

8(47.1)

pTNM category

   

0.075

 I

44

23(52.3)

21(47.7)

 

 II

29

15(51.7)

14(42.3)

 III

27

14(51.9)

13(48.1)

CA19-9 (U/mL)

   

< 0.001*

 ≥ 37

87

45(51.7)

42(48.3)

 

 < 37

13

7(53.9)

6(46.1)

  1. pT pathologic T, pN pathologic N, pTNM pathologic TNM
  2. *Values shown in bold italics are statistically significant